HEADER SIGNALING PROTEIN 03-FEB-16 5HZW TITLE CRYSTAL STRUCTURE OF THE ORPHAN REGION OF HUMAN ENDOGLIN/CD105 IN TITLE 2 COMPLEX WITH BMP9 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MALTOSE-BINDING PERIPLASMIC PROTEIN,ENDOGLIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 27-393,UNP RESIDUES 25-337,UNP RESIDUES 27- COMPND 5 393,UNP RESIDUES 25-337; COMPND 6 SYNONYM: MBP,MMBP,MALTODEXTRIN-BINDING PROTEIN; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: THIS PROTEIN IS A CHIMERA. RESIDUES 56-422 ARE FROM E. COMPND 10 COLI MALTOSE BINDING PROTEIN (MBP), CORRESPOND TO RESIDUES 27-393 OF COMPND 11 SWISS-PROT DATABASE ENTRY P0AEX9 AND CONTAIN MUTATIONS I57T, D137A, COMPND 12 K138A, E227A, N228A, A270H, K274H, K294A, A367V, I372V, E414A, E417A, COMPND 13 D418A AND R422N (CORRESPONDING TO I28T, D108A, K109A, E198A, N199A, COMPND 14 A241H, K245H, K265A, A338V, I343V, E385A, E388A, D389A AND R393N IN COMPND 15 P0AEX9). RESIDUES 426-737 ARE FROM HUMAN ENDOGLIN PROTEIN AND COMPND 16 CORRESPOND TO RESIDUES 26-337 OF SWISS-PROT DATABASE ENTRY P17813. COMPND 17 SUBTRACTING 400 FROM THE PDB ENTRY RESIDUE NUMBERING RESULTS IN THE COMPND 18 NUMBERING ACCORDING TO UNIPROT ENTRY P17813.; COMPND 19 MOL_ID: 2; COMPND 20 MOLECULE: GROWTH/DIFFERENTIATION FACTOR 2; COMPND 21 CHAIN: B; COMPND 22 FRAGMENT: UNP RESIDUES 320-429; COMPND 23 SYNONYM: GDF-2,BONE MORPHOGENETIC PROTEIN 9,BMP-9; COMPND 24 ENGINEERED: YES; COMPND 25 OTHER_DETAILS: MATURE BMP9 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI K12, HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 83333, 9606; SOURCE 5 CELL: ENDOTHELIAL; SOURCE 6 GENE: MALE, B4034, JW3994, ENG, END; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: HEK293S; SOURCE 11 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-3022; SOURCE 12 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 13 EXPRESSION_SYSTEM_PLASMID: PHLSEC; SOURCE 14 MOL_ID: 2; SOURCE 15 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 16 ORGANISM_COMMON: HUMAN; SOURCE 17 ORGANISM_TAXID: 9606; SOURCE 18 GENE: GDF2, BMP9; SOURCE 19 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 20 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 21 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 22 EXPRESSION_SYSTEM_CELL_LINE: HEK293S; SOURCE 23 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-3022; SOURCE 24 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 25 EXPRESSION_SYSTEM_PLASMID: PHLSEC KEYWDS ORPHAN DOMAIN, ANGIOGENESIS, GLYCOPROTEIN, RECEPTOR, SIGNALING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.BOKHOVE,T.SAITO,L.JOVINE REVDAT 6 23-OCT-24 5HZW 1 REMARK REVDAT 5 10-JAN-24 5HZW 1 HETSYN REVDAT 4 29-JUL-20 5HZW 1 COMPND REMARK HET HETNAM REVDAT 4 2 1 FORMUL SSBOND LINK SITE REVDAT 4 3 1 ATOM REVDAT 3 06-SEP-17 5HZW 1 REMARK REVDAT 2 14-JUN-17 5HZW 1 JRNL REVDAT 1 07-JUN-17 5HZW 0 JRNL AUTH T.SAITO,M.BOKHOVE,R.CROCI,S.ZAMORA-CABALLERO,L.HAN, JRNL AUTH 2 M.LETARTE,D.DE SANCTIS,L.JOVINE JRNL TITL STRUCTURAL BASIS OF THE HUMAN ENDOGLIN-BMP9 INTERACTION: JRNL TITL 2 INSIGHTS INTO BMP SIGNALING AND HHT1. JRNL REF CELL REP V. 19 1917 2017 JRNL REFN ESSN 2211-1247 JRNL PMID 28564608 JRNL DOI 10.1016/J.CELREP.2017.05.011 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.GOUGOS,M.LETARTE REMARK 1 TITL PRIMARY STRUCTURE OF ENDOGLIN, AN RGD-CONTAINING REMARK 1 TITL 2 GLYCOPROTEIN OF HUMAN ENDOTHELIAL CELLS. REMARK 1 REF J. BIOL. CHEM. V. 265 8361 1990 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 1692830 REMARK 1 REFERENCE 2 REMARK 1 AUTH M.SCHARPFENECKER,M.VAN DINTHER,Z.LIU,R.L.VAN BEZOOIJEN, REMARK 1 AUTH 2 Q.ZHAO,L.PUKAC,C.W.LOWIK,P.TEN DIJKE REMARK 1 TITL BMP-9 SIGNALS VIA ALK1 AND INHIBITS BFGF-INDUCED ENDOTHELIAL REMARK 1 TITL 2 CELL PROLIFERATION AND VEGF-STIMULATED ANGIOGENESIS. REMARK 1 REF J. CELL. SCI. V. 120 964 2007 REMARK 1 REFN ISSN 0021-9533 REMARK 1 PMID 17311849 REMARK 1 DOI 10.1242/JCS.002949 REMARK 1 REFERENCE 3 REMARK 1 AUTH R.CASTONGUAY,E.D.WERNER,R.G.MATTHEWS,E.PRESMAN,A.W.MULIVOR, REMARK 1 AUTH 2 N.SOLBAN,D.SAKO,R.S.PEARSALL,K.W.UNDERWOOD,J.SEEHRA,R.KUMAR, REMARK 1 AUTH 3 A.V.GRINBERG REMARK 1 TITL SOLUBLE ENDOGLIN SPECIFICALLY BINDS BONE MORPHOGENETIC REMARK 1 TITL 2 PROTEINS 9 AND 10 VIA ITS ORPHAN DOMAIN, INHIBITS BLOOD REMARK 1 TITL 3 VESSEL FORMATION, AND SUPPRESSES TUMOR GROWTH. REMARK 1 REF J. BIOL. CHEM. V. 286 30034 2011 REMARK 1 REFN ESSN 1083-351X REMARK 1 PMID 21737454 REMARK 1 DOI 10.1074/JBC.M111.260133 REMARK 1 REFERENCE 4 REMARK 1 AUTH A.ALT,L.MIGUEL-ROMERO,J.DONDERIS,M.ARISTORENA,F.J.BLANCO, REMARK 1 AUTH 2 A.ROUND,V.RUBIO,C.BERNABEU,A.MARINA REMARK 1 TITL STRUCTURAL AND FUNCTIONAL INSIGHTS INTO ENDOGLIN LIGAND REMARK 1 TITL 2 RECOGNITION AND BINDING. REMARK 1 REF PLOS ONE V. 7 29948 2012 REMARK 1 REFN ESSN 1932-6203 REMARK 1 PMID 22347366 REMARK 1 DOI 10.1371/JOURNAL.PONE.0029948 REMARK 1 REFERENCE 5 REMARK 1 AUTH O.NOLAN-STEVAUX,W.ZHONG,S.CULP,K.SHAFFER,J.HOOVER, REMARK 1 AUTH 2 D.WICKRAMASINGHE,A.RUEFLI-BRASSE REMARK 1 TITL ENDOGLIN REQUIREMENT FOR BMP9 SIGNALING IN ENDOTHELIAL CELLS REMARK 1 TITL 2 REVEALS NEW MECHANISM OF ACTION FOR SELECTIVE ANTI-ENDOGLIN REMARK 1 TITL 3 ANTIBODIES. REMARK 1 REF PLOS ONE V. 7 50920 2012 REMARK 1 REFN ESSN 1932-6203 REMARK 1 PMID 23300529 REMARK 1 DOI 10.1371/JOURNAL.PONE.0050920 REMARK 2 REMARK 2 RESOLUTION. 4.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.81 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.330 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 8611 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.289 REMARK 3 R VALUE (WORKING SET) : 0.286 REMARK 3 FREE R VALUE : 0.318 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.840 REMARK 3 FREE R VALUE TEST SET COUNT : 847 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 52.8149 - 8.0801 1.00 1336 166 0.2229 0.2706 REMARK 3 2 8.0801 - 6.4170 1.00 1298 144 0.3191 0.3356 REMARK 3 3 6.4170 - 5.6069 1.00 1286 151 0.3814 0.4003 REMARK 3 4 5.6069 - 5.0947 1.00 1287 129 0.3491 0.3697 REMARK 3 5 5.0947 - 4.7298 1.00 1268 141 0.3446 0.3382 REMARK 3 6 4.7298 - 4.4511 1.00 1290 116 0.3658 0.3903 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.660 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 39.520 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 219.0 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 6143 REMARK 3 ANGLE : 0.634 8377 REMARK 3 CHIRALITY : 0.044 951 REMARK 3 PLANARITY : 0.005 1075 REMARK 3 DIHEDRAL : 9.325 3678 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 59:388 OR RESI 1000) REMARK 3 ORIGIN FOR THE GROUP (A): 27.6408 -32.5548 -8.3505 REMARK 3 T TENSOR REMARK 3 T11: 2.8603 T22: 3.0418 REMARK 3 T33: 3.0789 T12: 0.0718 REMARK 3 T13: 0.2683 T23: -0.0275 REMARK 3 L TENSOR REMARK 3 L11: 1.4314 L22: 3.1155 REMARK 3 L33: 1.5778 L12: 0.9444 REMARK 3 L13: 1.1515 L23: -0.0672 REMARK 3 S TENSOR REMARK 3 S11: 0.0478 S12: 0.2005 S13: 0.8166 REMARK 3 S21: 0.0389 S22: -0.2102 S23: 0.1406 REMARK 3 S31: -0.3937 S32: -0.2941 S33: -0.0000 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 389:730 OR RESI 801 OR RESI REMARK 3 810) REMARK 3 ORIGIN FOR THE GROUP (A): 20.3422 -60.4868 6.3522 REMARK 3 T TENSOR REMARK 3 T11: 3.0278 T22: 2.8563 REMARK 3 T33: 2.9036 T12: -0.0021 REMARK 3 T13: 0.2407 T23: -0.0498 REMARK 3 L TENSOR REMARK 3 L11: 5.0774 L22: 2.2122 REMARK 3 L33: 2.3707 L12: 0.8793 REMARK 3 L13: 1.3044 L23: -0.1952 REMARK 3 S TENSOR REMARK 3 S11: 0.2246 S12: 0.0040 S13: -0.7433 REMARK 3 S21: 0.1501 S22: 0.1385 S23: 0.0678 REMARK 3 S31: -0.2907 S32: 0.3156 S33: 0.0000 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 6:16) REMARK 3 ORIGIN FOR THE GROUP (A): 39.1704 -90.1059 42.1687 REMARK 3 T TENSOR REMARK 3 T11: 3.6159 T22: 3.8743 REMARK 3 T33: 4.1242 T12: 0.3354 REMARK 3 T13: -0.1564 T23: -0.1476 REMARK 3 L TENSOR REMARK 3 L11: 0.0643 L22: 0.0311 REMARK 3 L33: 0.0554 L12: 0.0466 REMARK 3 L13: 0.0658 L23: 0.0489 REMARK 3 S TENSOR REMARK 3 S11: -0.1402 S12: -0.7811 S13: 0.8171 REMARK 3 S21: -0.1461 S22: -0.3284 S23: -0.1238 REMARK 3 S31: -0.8847 S32: 0.2915 S33: -0.0000 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 17:64) REMARK 3 ORIGIN FOR THE GROUP (A): 46.8781 -90.2148 40.3360 REMARK 3 T TENSOR REMARK 3 T11: 3.0666 T22: 2.8770 REMARK 3 T33: 3.1301 T12: 0.3664 REMARK 3 T13: -0.5305 T23: -0.0595 REMARK 3 L TENSOR REMARK 3 L11: 0.3982 L22: 0.0875 REMARK 3 L33: 0.4907 L12: -0.0135 REMARK 3 L13: -0.5081 L23: -0.0336 REMARK 3 S TENSOR REMARK 3 S11: 0.1737 S12: -0.7223 S13: -1.0690 REMARK 3 S21: 1.6901 S22: 0.9516 S23: 3.0320 REMARK 3 S31: -0.2809 S32: -0.8161 S33: 0.0021 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: CHAIN 'B' AND (RESID 65:110) REMARK 3 ORIGIN FOR THE GROUP (A): 46.8046 -83.2682 33.7533 REMARK 3 T TENSOR REMARK 3 T11: 3.0377 T22: 3.4795 REMARK 3 T33: 3.2237 T12: 0.2723 REMARK 3 T13: -0.4942 T23: -0.2488 REMARK 3 L TENSOR REMARK 3 L11: 0.9644 L22: 1.2150 REMARK 3 L33: 0.6837 L12: 0.6835 REMARK 3 L13: 0.8086 L23: 0.8302 REMARK 3 S TENSOR REMARK 3 S11: -0.2906 S12: 1.2564 S13: 0.6316 REMARK 3 S21: 0.4217 S22: -1.4158 S23: -1.4346 REMARK 3 S31: 0.2064 S32: -0.4996 S33: -0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HZW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-FEB-16. REMARK 100 THE DEPOSITION ID IS D_1000215848. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I02 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97938 REMARK 200 MONOCHROMATOR : SI SINGLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : PSI PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DIALS 1.DEV.176 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.525 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9558 REMARK 200 RESOLUTION RANGE HIGH (A) : 4.301 REMARK 200 RESOLUTION RANGE LOW (A) : 52.811 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 9.500 REMARK 200 R MERGE (I) : 0.39500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 3.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 4.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 4.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 9.70 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER (2.5.6) REMARK 200 STARTING MODEL: 3SEX, 5I04, 5I05 REMARK 200 REMARK 200 REMARK: HEXAGONAL BIPYRAMID REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.1 M AMMONIUM TARTRATE, PH 7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z REMARK 290 5555 Y,-X+Y,Z+1/3 REMARK 290 6555 X-Y,X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 17.72133 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 35.44267 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 17.72133 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 35.44267 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 34640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 105.62250 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -182.94354 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 47 REMARK 465 THR A 48 REMARK 465 GLY A 49 REMARK 465 HIS A 50 REMARK 465 HIS A 51 REMARK 465 HIS A 52 REMARK 465 HIS A 53 REMARK 465 HIS A 54 REMARK 465 HIS A 55 REMARK 465 LYS A 56 REMARK 465 THR A 57 REMARK 465 GLU A 58 REMARK 465 ASN A 488 REMARK 465 GLY A 489 REMARK 465 THR A 490 REMARK 465 TRP A 491 REMARK 465 GLY A 731 REMARK 465 GLY A 732 REMARK 465 ARG A 733 REMARK 465 LEU A 734 REMARK 465 GLN A 735 REMARK 465 THR A 736 REMARK 465 SER A 737 REMARK 465 SER B 1 REMARK 465 ALA B 2 REMARK 465 GLY B 3 REMARK 465 ALA B 4 REMARK 465 GLY B 5 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 269 HD22 ASN A 289 1.42 REMARK 500 O SER B 6 H GLY B 40 1.55 REMARK 500 O LYS A 244 HG1 THR A 248 1.60 REMARK 500 ND2 ASN A 521 O5 NAG A 802 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 SG CYS B 73 SG CYS B 73 4545 2.03 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 336 -70.71 -57.95 REMARK 500 GLU A 426 54.24 35.96 REMARK 500 PRO A 472 170.38 -55.08 REMARK 500 TYR A 520 -178.34 -171.01 REMARK 500 SER A 628 75.11 61.47 REMARK 500 PHE A 682 69.17 38.65 REMARK 500 GLU A 684 -176.43 -68.45 REMARK 500 LYS A 685 64.40 63.33 REMARK 500 SER A 729 -6.77 92.39 REMARK 500 TYR B 35 135.76 -36.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5I04 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ORPHAN REGION OF HUMAN ENDOGLIN/CD105 REMARK 900 RELATED ID: 5HZV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ZONA PELLUCIDA MODULE OF HUMAN ENDOGLIN/ REMARK 900 CD105 REMARK 900 RELATED ID: 5I05 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN BMP9 AT 1.87 A RESOLUTION DBREF 5HZW A 56 422 UNP P0AEX9 MALE_ECOLI 27 393 DBREF 5HZW A 426 737 UNP P17813 EGLN_HUMAN 26 337 DBREF 5HZW B 1 110 UNP Q9UK05 GDF2_HUMAN 320 429 SEQADV 5HZW GLU A 47 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW THR A 48 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW GLY A 49 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW HIS A 50 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW HIS A 51 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW HIS A 52 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW HIS A 53 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW HIS A 54 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW HIS A 55 UNP P0AEX9 EXPRESSION TAG SEQADV 5HZW THR A 57 UNP P0AEX9 ILE 28 ENGINEERED MUTATION SEQADV 5HZW ALA A 137 UNP P0AEX9 ASP 108 ENGINEERED MUTATION SEQADV 5HZW ALA A 138 UNP P0AEX9 LYS 109 ENGINEERED MUTATION SEQADV 5HZW ALA A 227 UNP P0AEX9 GLU 198 ENGINEERED MUTATION SEQADV 5HZW ALA A 228 UNP P0AEX9 ASN 199 ENGINEERED MUTATION SEQADV 5HZW HIS A 270 UNP P0AEX9 ALA 241 ENGINEERED MUTATION SEQADV 5HZW HIS A 274 UNP P0AEX9 LYS 245 ENGINEERED MUTATION SEQADV 5HZW ALA A 294 UNP P0AEX9 LYS 265 ENGINEERED MUTATION SEQADV 5HZW VAL A 367 UNP P0AEX9 ALA 338 ENGINEERED MUTATION SEQADV 5HZW VAL A 372 UNP P0AEX9 ILE 343 ENGINEERED MUTATION SEQADV 5HZW ALA A 414 UNP P0AEX9 GLU 385 ENGINEERED MUTATION SEQADV 5HZW ALA A 417 UNP P0AEX9 LYS 388 ENGINEERED MUTATION SEQADV 5HZW ALA A 418 UNP P0AEX9 ASP 389 ENGINEERED MUTATION SEQADV 5HZW ASN A 422 UNP P0AEX9 ARG 393 ENGINEERED MUTATION SEQADV 5HZW ALA A 423 UNP P0AEX9 LINKER SEQADV 5HZW ALA A 424 UNP P0AEX9 LINKER SEQADV 5HZW ALA A 425 UNP P0AEX9 LINKER SEQRES 1 A 691 GLU THR GLY HIS HIS HIS HIS HIS HIS LYS THR GLU GLU SEQRES 2 A 691 GLY LYS LEU VAL ILE TRP ILE ASN GLY ASP LYS GLY TYR SEQRES 3 A 691 ASN GLY LEU ALA GLU VAL GLY LYS LYS PHE GLU LYS ASP SEQRES 4 A 691 THR GLY ILE LYS VAL THR VAL GLU HIS PRO ASP LYS LEU SEQRES 5 A 691 GLU GLU LYS PHE PRO GLN VAL ALA ALA THR GLY ASP GLY SEQRES 6 A 691 PRO ASP ILE ILE PHE TRP ALA HIS ASP ARG PHE GLY GLY SEQRES 7 A 691 TYR ALA GLN SER GLY LEU LEU ALA GLU ILE THR PRO ALA SEQRES 8 A 691 ALA ALA PHE GLN ASP LYS LEU TYR PRO PHE THR TRP ASP SEQRES 9 A 691 ALA VAL ARG TYR ASN GLY LYS LEU ILE ALA TYR PRO ILE SEQRES 10 A 691 ALA VAL GLU ALA LEU SER LEU ILE TYR ASN LYS ASP LEU SEQRES 11 A 691 LEU PRO ASN PRO PRO LYS THR TRP GLU GLU ILE PRO ALA SEQRES 12 A 691 LEU ASP LYS GLU LEU LYS ALA LYS GLY LYS SER ALA LEU SEQRES 13 A 691 MET PHE ASN LEU GLN GLU PRO TYR PHE THR TRP PRO LEU SEQRES 14 A 691 ILE ALA ALA ASP GLY GLY TYR ALA PHE LYS TYR ALA ALA SEQRES 15 A 691 GLY LYS TYR ASP ILE LYS ASP VAL GLY VAL ASP ASN ALA SEQRES 16 A 691 GLY ALA LYS ALA GLY LEU THR PHE LEU VAL ASP LEU ILE SEQRES 17 A 691 LYS ASN LYS HIS MET ASN ALA ASP THR ASP TYR SER ILE SEQRES 18 A 691 ALA GLU HIS ALA PHE ASN HIS GLY GLU THR ALA MET THR SEQRES 19 A 691 ILE ASN GLY PRO TRP ALA TRP SER ASN ILE ASP THR SER SEQRES 20 A 691 ALA VAL ASN TYR GLY VAL THR VAL LEU PRO THR PHE LYS SEQRES 21 A 691 GLY GLN PRO SER LYS PRO PHE VAL GLY VAL LEU SER ALA SEQRES 22 A 691 GLY ILE ASN ALA ALA SER PRO ASN LYS GLU LEU ALA LYS SEQRES 23 A 691 GLU PHE LEU GLU ASN TYR LEU LEU THR ASP GLU GLY LEU SEQRES 24 A 691 GLU ALA VAL ASN LYS ASP LYS PRO LEU GLY ALA VAL ALA SEQRES 25 A 691 LEU LYS SER TYR GLU GLU GLU LEU VAL LYS ASP PRO ARG SEQRES 26 A 691 VAL ALA ALA THR MET GLU ASN ALA GLN LYS GLY GLU ILE SEQRES 27 A 691 MET PRO ASN ILE PRO GLN MET SER ALA PHE TRP TYR ALA SEQRES 28 A 691 VAL ARG THR ALA VAL ILE ASN ALA ALA SER GLY ARG GLN SEQRES 29 A 691 THR VAL ASP ALA ALA LEU ALA ALA ALA GLN THR ASN ALA SEQRES 30 A 691 ALA ALA GLU THR VAL HIS CYS ASP LEU GLN PRO VAL GLY SEQRES 31 A 691 PRO GLU ARG GLY GLU VAL THR TYR THR THR SER GLN VAL SEQRES 32 A 691 SER LYS GLY CYS VAL ALA GLN ALA PRO ASN ALA ILE LEU SEQRES 33 A 691 GLU VAL HIS VAL LEU PHE LEU GLU PHE PRO THR GLY PRO SEQRES 34 A 691 SER GLN LEU GLU LEU THR LEU GLN ALA SER LYS GLN ASN SEQRES 35 A 691 GLY THR TRP PRO ARG GLU VAL LEU LEU VAL LEU SER VAL SEQRES 36 A 691 ASN SER SER VAL PHE LEU HIS LEU GLN ALA LEU GLY ILE SEQRES 37 A 691 PRO LEU HIS LEU ALA TYR ASN SER SER LEU VAL THR PHE SEQRES 38 A 691 GLN GLU PRO PRO GLY VAL ASN THR THR GLU LEU PRO SER SEQRES 39 A 691 PHE PRO LYS THR GLN ILE LEU GLU TRP ALA ALA GLU ARG SEQRES 40 A 691 GLY PRO ILE THR SER ALA ALA GLU LEU ASN ASP PRO GLN SEQRES 41 A 691 SER ILE LEU LEU ARG LEU GLY GLN ALA GLN GLY SER LEU SEQRES 42 A 691 SER PHE CYS MET LEU GLU ALA SER GLN ASP MET GLY ARG SEQRES 43 A 691 THR LEU GLU TRP ARG PRO ARG THR PRO ALA LEU VAL ARG SEQRES 44 A 691 GLY CYS HIS LEU GLU GLY VAL ALA GLY HIS LYS GLU ALA SEQRES 45 A 691 HIS ILE LEU ARG VAL LEU PRO GLY HIS SER ALA GLY PRO SEQRES 46 A 691 ARG THR VAL THR VAL LYS VAL GLU LEU SER CYS ALA PRO SEQRES 47 A 691 GLY ASP LEU ASP ALA VAL LEU ILE LEU GLN GLY PRO PRO SEQRES 48 A 691 TYR VAL SER TRP LEU ILE ASP ALA ASN HIS ASN MET GLN SEQRES 49 A 691 ILE TRP THR THR GLY GLU TYR SER PHE LYS ILE PHE PRO SEQRES 50 A 691 GLU LYS ASN ILE ARG GLY PHE LYS LEU PRO ASP THR PRO SEQRES 51 A 691 GLN GLY LEU LEU GLY GLU ALA ARG MET LEU ASN ALA SER SEQRES 52 A 691 ILE VAL ALA SER PHE VAL GLU LEU PRO LEU ALA SER ILE SEQRES 53 A 691 VAL SER LEU HIS ALA SER SER CYS GLY GLY ARG LEU GLN SEQRES 54 A 691 THR SER SEQRES 1 B 110 SER ALA GLY ALA GLY SER HIS CYS GLN LYS THR SER LEU SEQRES 2 B 110 ARG VAL ASN PHE GLU ASP ILE GLY TRP ASP SER TRP ILE SEQRES 3 B 110 ILE ALA PRO LYS GLU TYR GLU ALA TYR GLU CYS LYS GLY SEQRES 4 B 110 GLY CYS PHE PHE PRO LEU ALA ASP ASP VAL THR PRO THR SEQRES 5 B 110 LYS HIS ALA ILE VAL GLN THR LEU VAL HIS LEU LYS PHE SEQRES 6 B 110 PRO THR LYS VAL GLY LYS ALA CYS CYS VAL PRO THR LYS SEQRES 7 B 110 LEU SER PRO ILE SER VAL LEU TYR LYS ASP ASP MET GLY SEQRES 8 B 110 VAL PRO THR LEU LYS TYR HIS TYR GLU GLY MET SER VAL SEQRES 9 B 110 ALA GLU CYS GLY CYS ARG HET GLC C 1 23 HET GLC C 2 22 HET NAG A 801 28 HET NAG A 802 28 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 GLC 2(C6 H12 O6) FORMUL 4 NAG 2(C8 H15 N O6) HELIX 1 AA1 GLY A 71 GLY A 87 1 17 HELIX 2 AA2 LYS A 97 ALA A 107 1 11 HELIX 3 AA3 HIS A 119 SER A 128 1 10 HELIX 4 AA4 ALA A 137 LEU A 144 1 8 HELIX 5 AA5 TYR A 145 VAL A 152 1 8 HELIX 6 AA6 THR A 183 GLU A 185 5 3 HELIX 7 AA7 GLU A 186 LYS A 197 1 12 HELIX 8 AA8 GLU A 208 PHE A 211 5 4 HELIX 9 AA9 THR A 212 ALA A 217 1 6 HELIX 10 AB1 ALA A 218 GLY A 220 5 3 HELIX 11 AB2 ASN A 240 ASN A 256 1 17 HELIX 12 AB3 ASP A 264 HIS A 274 1 11 HELIX 13 AB4 TRP A 285 SER A 293 1 9 HELIX 14 AB5 ASN A 327 TYR A 338 1 12 HELIX 15 AB6 THR A 341 LYS A 352 1 12 HELIX 16 AB7 LEU A 359 VAL A 367 1 9 HELIX 17 AB8 ASP A 369 GLY A 382 1 14 HELIX 18 AB9 GLN A 390 SER A 407 1 18 HELIX 19 AC1 THR A 411 ALA A 424 1 14 HELIX 20 AC2 PRO A 542 GLU A 552 1 11 HELIX 21 AC3 THR A 695 LEU A 706 1 12 HELIX 22 AC4 THR B 52 PHE B 65 1 14 SHEET 1 AA1 5 ILE A 88 GLU A 93 0 SHEET 2 AA1 5 GLY A 60 TRP A 65 1 N LEU A 62 O THR A 91 SHEET 3 AA1 5 ILE A 114 ALA A 118 1 O ILE A 114 N VAL A 63 SHEET 4 AA1 5 PHE A 313 ILE A 321 -1 O SER A 318 N TRP A 117 SHEET 5 AA1 5 ALA A 160 GLU A 166 -1 N ILE A 163 O LEU A 317 SHEET 1 AA2 5 ILE A 88 GLU A 93 0 SHEET 2 AA2 5 GLY A 60 TRP A 65 1 N LEU A 62 O THR A 91 SHEET 3 AA2 5 ILE A 114 ALA A 118 1 O ILE A 114 N VAL A 63 SHEET 4 AA2 5 PHE A 313 ILE A 321 -1 O SER A 318 N TRP A 117 SHEET 5 AA2 5 GLU A 383 ILE A 384 1 O GLU A 383 N VAL A 314 SHEET 1 AA3 2 ARG A 153 TYR A 154 0 SHEET 2 AA3 2 LYS A 157 LEU A 158 -1 O LYS A 157 N TYR A 154 SHEET 1 AA4 4 SER A 200 LEU A 202 0 SHEET 2 AA4 4 THR A 277 ASN A 282 1 O ALA A 278 N SER A 200 SHEET 3 AA4 4 SER A 169 ASN A 173 -1 N ASN A 173 O ALA A 278 SHEET 4 AA4 4 TYR A 297 THR A 300 -1 O GLY A 298 N TYR A 172 SHEET 1 AA5 2 LYS A 225 ALA A 227 0 SHEET 2 AA5 2 LYS A 230 ASP A 232 -1 O ASP A 232 N LYS A 225 SHEET 1 AA6 2 THR A 304 PHE A 305 0 SHEET 2 AA6 2 GLN A 308 PRO A 309 -1 O GLN A 308 N PHE A 305 SHEET 1 AA7 8 GLN A 433 PRO A 434 0 SHEET 2 AA7 8 ARG A 605 HIS A 608 -1 O GLY A 606 N GLN A 433 SHEET 3 AA7 8 ILE A 710 LEU A 717 -1 O VAL A 711 N CYS A 607 SHEET 4 AA7 8 GLU A 617 VAL A 623 1 N ILE A 620 O SER A 713 SHEET 5 AA7 8 ALA A 649 GLN A 654 1 O ILE A 652 N LEU A 621 SHEET 6 AA7 8 MET A 669 THR A 673 1 O GLN A 670 N ALA A 649 SHEET 7 AA7 8 PRO B 93 CYS B 109 -1 O LEU B 95 N MET A 669 SHEET 8 AA7 8 CYS B 74 LYS B 87 -1 N LYS B 78 O ALA B 105 SHEET 1 AA8 6 GLY A 440 THR A 446 0 SHEET 2 AA8 6 ALA A 720 ALA A 727 -1 O SER A 724 N THR A 443 SHEET 3 AA8 6 ARG A 632 LEU A 640 1 N THR A 635 O SER A 721 SHEET 4 AA8 6 VAL A 659 ASP A 664 1 O SER A 660 N ARG A 632 SHEET 5 AA8 6 GLU A 676 PHE A 679 1 O GLU A 676 N TRP A 661 SHEET 6 AA8 6 ILE A 687 ARG A 688 -1 O ILE A 687 N TYR A 677 SHEET 1 AA9 6 LEU A 516 ALA A 519 0 SHEET 2 AA9 6 GLU A 494 VAL A 501 1 N LEU A 499 O ALA A 519 SHEET 3 AA9 6 LEU A 462 GLU A 470 1 N LEU A 469 O SER A 500 SHEET 4 AA9 6 ILE A 556 ASN A 563 1 O LEU A 562 N PHE A 468 SHEET 5 AA9 6 GLN A 448 VAL A 454 -1 N LYS A 451 O GLU A 561 SHEET 6 AA9 6 GLU A 585 ASP A 589 -1 O GLU A 585 N GLY A 452 SHEET 1 AB1 5 VAL A 525 PHE A 527 0 SHEET 2 AB1 5 VAL A 505 ALA A 511 1 N LEU A 507 O THR A 526 SHEET 3 AB1 5 SER A 476 GLN A 483 1 N SER A 476 O PHE A 506 SHEET 4 AB1 5 PRO A 565 ARG A 571 1 O LEU A 570 N GLN A 483 SHEET 5 AB1 5 LEU A 594 PRO A 598 -1 O ARG A 597 N GLN A 566 SHEET 1 AB2 2 GLN B 9 THR B 11 0 SHEET 2 AB2 2 GLU B 36 LYS B 38 -1 O GLU B 36 N THR B 11 SHEET 1 AB3 2 ARG B 14 ASN B 16 0 SHEET 2 AB3 2 GLU B 31 GLU B 33 -1 O TYR B 32 N VAL B 15 SSBOND 1 CYS A 430 CYS A 607 1555 1555 2.03 SSBOND 2 CYS A 453 CYS A 582 1555 1555 2.03 SSBOND 3 CYS A 642 CYS A 730 1555 1555 2.03 SSBOND 4 CYS B 8 CYS B 74 1555 1555 2.02 SSBOND 5 CYS B 37 CYS B 107 1555 1555 2.03 SSBOND 6 CYS B 41 CYS B 109 1555 1555 2.04 LINK ND2 ASN A 502 C1 NAG A 801 1555 1555 1.39 LINK ND2 ASN A 521 C1 NAG A 802 1555 1555 1.41 LINK O4 GLC C 1 C1 GLC C 2 1555 1555 1.41 CISPEP 1 ALA B 28 PRO B 29 0 -3.56 CISPEP 2 PHE B 43 PRO B 44 0 0.27 CRYST1 211.245 211.245 53.164 90.00 90.00 120.00 P 64 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.004734 0.002733 0.000000 0.00000 SCALE2 0.000000 0.005466 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018810 0.00000